Want to join the conversation?
Biopharmaceutical company $AMGN said that in Phase 2 confirmatory multicenter single-arm trial (BLAST) for adult patients having B-cell precursor acute lymphoblastic leukemia with minimal residual disease (MRD), i.e. cancer cells from bone marrow, who received BLINCYTO monotherapy showed clinically relapse-free survival (RFS).
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.